The Center for Liver Diseases/Hepatology provides comprehensive prevention, diagnostic, evaluation, treatment, management and consultation services for patients with all types of liver diseases, including:

  • Hepatitis A, B, and C
  • Cirrhosis
  • Primary biliary cirrhosis
  • Sclerosing cholangitis
  • Complications of portal hypertension
  • Alcoholic liver disease
  • Cancer of the liver and bile duct

Diagnostic tests ordered through the Center for Liver Diseases include lab tests, CT scans, ultrasounds, MRIs and liver biopsies. Treatment may include medications, including pegylated interferon or novel medications currently in clinical trials for hepatitis or various surgical procedures. If a patient requires a liver transplant, he/she will be assessed at the Center and placed on a transplant list.

Valley also offers a non-invasive imaging test called FibroScan, which can accurately detect the amount of fibrosis or scarring in the liver and minimize the need for a liver biopsy. This test uses ultrasound technology to measure liver stiffness and fatty changes in the liver. Your Valley gastroenterologist will determine if this test is right for you.

Our Hepatologists

The hepatologist practicing at Valley's Center For Liver Diseases/Hepatology is:

Joseph A. Odin, MD, PhD

Joseph A. Odin, MD, PhD, is a gastroenterologist/hepatologist based at Mount Sinai Hospital. His clinical focus includes upper GI endoscopy including surveillance of esophageal varices and endoscopic band ligation; fibroscan elastography; liver biopsy; jaundice; ascites; abnormal liver tests; acute liver failure; cirrhosis; portal hypertension; alcoholic and non-alcoholic fatty liver disease; autoimmune hepatitis; primary biliary cholangitis; primary sclerosing cholangitis; hepatitis A, B and C, liver transplantation evaluation and post-transplant care; toxic hepatitis; drug-induced liver injury; liver masses and cancer; hemochromatosis; and Wilsons disease.

He graduated from the Icahn School of Medicine at Mount Sinai of the City University of New York in 1993, where he received his PhD in immunology. He completed a residency in internal medicine at the Mount Sinai Hospital and a fellowship in gastroenterology/hepatology at John Hopkins Hospital.

Dr. Odin is a Professor of Medicine in the Division of Liver Diseases and the Recanati/Miller Transplantation Institute. He is co-director of the Mount Sinai Autoimmune Liver Disease Program. He has research interest in liver autoimmunity and toxicology. His current research studies are focused on novel treatments for primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis and on the toxic effects of medications, including herbal and dietary supplements on the liver. He cares for individuals with all liver diseases, including those with liver transplants.

Dr. Odin is affiliated with Mount Sinai Hospital in New York City. Patients are usually referred to the center by gastroenterologists.